Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1832 4
1833 2
1841 1
1842 1
1843 1
1844 1
1846 1
1849 1
1852 1
1859 1
1866 4
1898 3
1899 2
1902 2
1903 2
1905 3
1906 2
1908 1
1910 2
1913 1
1917 1
1921 1
1922 2
1924 3
1925 1
1926 2
1927 1
1929 3
1931 1
1932 2
1933 1
1935 1
1936 1
1937 1
1939 2
1940 3
1941 3
1942 4
1943 6
1944 3
1945 4
1946 24
1947 16
1948 9
1949 10
1950 11
1951 12
1952 8
1953 13
1954 12
1955 10
1956 11
1957 19
1958 18
1959 18
1960 33
1961 22
1962 14
1963 23
1964 23
1965 19
1966 26
1967 30
1968 36
1969 34
1970 39
1971 57
1972 51
1973 55
1974 52
1975 36
1976 50
1977 51
1978 63
1979 65
1980 52
1981 66
1982 68
1983 77
1984 75
1985 81
1986 80
1987 98
1988 83
1989 86
1990 123
1991 92
1992 106
1993 119
1994 135
1995 126
1996 137
1997 123
1998 123
1999 150
2000 150
2001 171
2002 163
2003 168
2004 191
2005 211
2006 263
2007 258
2008 263
2009 293
2010 288
2011 341
2012 389
2013 365
2014 362
2015 387
2016 448
2017 468
2018 470
2019 429
2020 410
2021 487
2022 437
2023 409
2024 184

Text availability

Article attribute

Article type

Publication date

Search Results

10,167 results

Results by year

Filters applied: . Clear all
Page 1
A New Framework for Dementia Nomenclature.
Petersen RC, Weintraub S, Sabbagh M, Karlawish J, Adler CH, Dilworth-Anderson P, Frank L, Huling Hummel C, Taylor A; Dementia Nomenclature Initiative. Petersen RC, et al. Among authors: taylor a. JAMA Neurol. 2023 Dec 1;80(12):1364-1370. doi: 10.1001/jamaneurol.2023.3664. JAMA Neurol. 2023. PMID: 37843871 Review.
PARP inhibitors in metastatic prostate cancer.
Taylor AK, Kosoff D, Emamekhoo H, Lang JM, Kyriakopoulos CE. Taylor AK, et al. Front Oncol. 2023 Apr 24;13:1159557. doi: 10.3389/fonc.2023.1159557. eCollection 2023. Front Oncol. 2023. PMID: 37168382 Free PMC article. Review.
Mesolimbic dopamine release conveys causal associations.
Jeong H, Taylor A, Floeder JR, Lohmann M, Mihalas S, Wu B, Zhou M, Burke DA, Namboodiri VMK. Jeong H, et al. Among authors: taylor a. Science. 2022 Dec 23;378(6626):eabq6740. doi: 10.1126/science.abq6740. Epub 2022 Dec 23. Science. 2022. PMID: 36480599 Free PMC article.
Oncogene-like addiction to aneuploidy in human cancers.
Girish V, Lakhani AA, Thompson SL, Scaduto CM, Brown LM, Hagenson RA, Sausville EL, Mendelson BE, Kandikuppa PK, Lukow DA, Yuan ML, Stevens EC, Lee SN, Schukken KM, Akalu SM, Vasudevan A, Zou C, Salovska B, Li W, Smith JC, Taylor AM, Martienssen RA, Liu Y, Sun R, Sheltzer JM. Girish V, et al. Among authors: taylor am. Science. 2023 Aug 25;381(6660):eadg4521. doi: 10.1126/science.adg4521. Epub 2023 Aug 25. Science. 2023. PMID: 37410869 Free PMC article.
[11C]metomidate PET-CT versus adrenal vein sampling for diagnosing surgically curable primary aldosteronism: a prospective, within-patient trial.
Wu X, Senanayake R, Goodchild E, Bashari WA, Salsbury J, Cabrera CP, Argentesi G, O'Toole SM, Matson M, Koo B, Parvanta L, Hilliard N, Kosmoliaptsis V, Marker A, Berney DM, Tan W, Foo R, Mein CA, Wozniak E, Savage E, Sahdev A, Bird N, Laycock K, Boros I, Hader S, Warnes V, Gillett D, Dawnay A, Adeyeye E, Prete A, Taylor AE, Arlt W, Bhuva AN, Aigbirhio F, Manisty C, McIntosh A, McConnachie A, Cruickshank JK, Cheow H, Gurnell M, Drake WM, Brown MJ. Wu X, et al. Among authors: taylor ae. Nat Med. 2023 Jan;29(1):190-202. doi: 10.1038/s41591-022-02114-5. Epub 2023 Jan 16. Nat Med. 2023. PMID: 36646800 Free PMC article. Clinical Trial.
Orthostatic Hypotension, Hypertension Treatment, and Cardiovascular Disease: An Individual Participant Meta-Analysis.
Juraschek SP, Hu JR, Cluett JL, Ishak AM, Mita C, Lipsitz LA, Appel LJ, Beckett NS, Coleman RL, Cushman WC, Davis BR, Grandits G, Holman RR, Miller ER 3rd, Peters R, Staessen JA, Taylor AA, Thijs L, Wright JT Jr, Mukamal KJ. Juraschek SP, et al. Among authors: taylor aa. JAMA. 2023 Oct 17;330(15):1459-1471. doi: 10.1001/jama.2023.18497. JAMA. 2023. PMID: 37847274 Free PMC article.
Air Versus Oxygen in ST-Segment-Elevation Myocardial Infarction.
Stub D, Smith K, Bernard S, Nehme Z, Stephenson M, Bray JE, Cameron P, Barger B, Ellims AH, Taylor AJ, Meredith IT, Kaye DM; AVOID Investigators. Stub D, et al. Among authors: taylor aj. Circulation. 2015 Jun 16;131(24):2143-50. doi: 10.1161/CIRCULATIONAHA.114.014494. Epub 2015 May 22. Circulation. 2015. PMID: 26002889 Free article. Clinical Trial.
RLY-4008, the First Highly Selective FGFR2 Inhibitor with Activity across FGFR2 Alterations and Resistance Mutations.
Subbiah V, Sahai V, Maglic D, Bruderek K, Touré BB, Zhao S, Valverde R, O'Hearn PJ, Moustakas DT, Schönherr H, Gerami-Moayed N, Taylor AM, Hudson BM, Houde DJ, Pal D, Foster L, Gunaydin H, Ayaz P, Sharon DA, Goyal L, Schram AM, Kamath S, Sherwin CA, Schmidt-Kittler O, Jen KY, Ricard F, Wolf BB, Shaw DE, Bergstrom DA, Watters J, Casaletto JB. Subbiah V, et al. Among authors: taylor am. Cancer Discov. 2023 Sep 6;13(9):2012-2031. doi: 10.1158/2159-8290.CD-23-0475. Cancer Discov. 2023. PMID: 37270847 Free PMC article.
Cancer aneuploidies are shaped primarily by effects on tumour fitness.
Shih J, Sarmashghi S, Zhakula-Kostadinova N, Zhang S, Georgis Y, Hoyt SH, Cuoco MS, Gao GF, Spurr LF, Berger AC, Ha G, Rendo V, Shen H, Meyerson M, Cherniack AD, Taylor AM, Beroukhim R. Shih J, et al. Among authors: taylor am. Nature. 2023 Jul;619(7971):793-800. doi: 10.1038/s41586-023-06266-3. Epub 2023 Jun 28. Nature. 2023. PMID: 37380777 Free PMC article.
10,167 results
You have reached the last available page of results. Please see the User Guide for more information.